Prelude Therapeutics Inc Quarterly Return On Assets in % from Q2 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Prelude Therapeutics Inc quarterly/annual Return On Assets history and growth rate from Q2 2021 to Q3 2024.
  • Prelude Therapeutics Inc Return On Assets for the quarter ending September 30, 2024 was -55.6 %, a 13.4% decline year-over-year.
  • Prelude Therapeutics Inc annual Return On Assets for 2023 was -48 %, a 4.23% decline from 2022.
  • Prelude Therapeutics Inc annual Return On Assets for 2022 was -46.1 %, a 39.8% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -55.6 -6.57 -13.4% Jul 1, 2024 Sep 30, 2024
Q2 2024 -51.6 -1.96 -3.95% Apr 1, 2024 Jun 30, 2024
Q1 2024 -47.2 +2.22 +4.49% Jan 1, 2024 Mar 31, 2024
Q4 2023 -48 -1.95 -4.23% Oct 1, 2023 Dec 31, 2023
Q3 2023 -49 -5 -11.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 -49.6 -8.65 -21.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 -49.4 -11.6 -30.6% Jan 1, 2023 Mar 31, 2023
Q4 2022 -46.1 -13.1 -39.8% Oct 1, 2022 Dec 31, 2022
Q3 2022 -44 -13.2 -42.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 -40.9 -12.5 -43.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -37.9 Jan 1, 2022 Mar 31, 2022
Q4 2021 -33 Oct 1, 2021 Dec 31, 2021
Q3 2021 -30.8 Jul 1, 2021 Sep 30, 2021
Q2 2021 -28.5 Apr 1, 2021 Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.